About Biognosys
Biognosys is a company based in Schlieren (Switzerland) founded in 2008 was acquired by Bruker in January 2023.. Biognosys has raised $9.13 million across 9 funding rounds from investors including Zurcher Kantonalbank, Bruker and European Union. Biognosys offers products and services including TrueDiscovery, Spectronaut, and NULISAseq. Biognosys operates in a competitive market with competitors including Somalogic, Cyrus Biotechnology, Vividion Therapeutics, Nautilus Biotechnology and Amunix, among others.
- Headquarter Schlieren, Switzerland
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Biognosys Ag
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$9.13 M (USD)
in 9 rounds
-
Latest Funding Round
-
Investors
Zurcher Kantonalbank
& 5 more
-
Employee Count
Employee Count
-
Acquired by
Bruker
(Jan 04, 2023)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Biognosys
Biognosys offers a comprehensive portfolio of products and services, including TrueDiscovery, Spectronaut, and NULISAseq. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Service for plasma and tissue biomarker identification
Software for DIA proteomics data processing
Multiplex assays for inflammation and CNS protein analysis
Funding Insights of Biognosys
Biognosys has successfully raised a total of $9.13M across 9 strategic funding rounds. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 9
- Last Round Last Round
- First Round First Round
- Investors Count 5
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Aug, 2019 | Amount | Series G - Biognosys | Valuation |
investors |
|
| Jul, 2017 | Amount | Series C - Biognosys | Valuation |
investors |
|
| Mar, 2016 | Amount | Grant - Biognosys | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Biognosys
Biognosys has secured backing from 6 investors, including institutional, venture fund, and angel investors. Prominent investors backing the company include Zurcher Kantonalbank, Bruker and European Union. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Early-stage investments are directed toward ICT and health tech startups.
|
Founded Year | Domain | Location | |
|
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability
|
Founded Year | Domain | Location | |
|
Commercial banking services are provided across Switzerland by Zurcher Kantonalbank.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Biognosys
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Biognosys
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Biognosys Comparisons
Competitors of Biognosys
Biognosys operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Somalogic, Cyrus Biotechnology, Vividion Therapeutics, Nautilus Biotechnology and Amunix, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Protein-based assays are developed for life science research.
|
|
| domain | founded_year | HQ Location |
Cloud-based protein-modeling software is developed for drug discovery.
|
|
| domain | founded_year | HQ Location |
Developing novel drugs based on a proteome-wide ligand and target discovery platform
|
|
| domain | founded_year | HQ Location |
A proteomics platform is developed for analyzing the human proteome.
|
|
| domain | founded_year | HQ Location |
Peptide-based therapeutics are developed for cancers and immune disorders.
|
|
| domain | founded_year | HQ Location |
Proteomics platform developed for early cancer and neurological disease detection.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Biognosys
Frequently Asked Questions about Biognosys
When was Biognosys founded?
Biognosys was founded in 2008 and raised its 1st funding round 1 year after it was founded.
Where is Biognosys located?
Biognosys is headquartered in Schlieren, Switzerland. It is registered at Schlieren, Zurich, Switzerland.
Is Biognosys a funded company?
Biognosys is a funded company, having raised a total of $9.13M across 9 funding rounds to date.
What does Biognosys do?
Biognosys was founded in 2008 in Schlieren, Switzerland, and operates within the proteomics sector. Two platforms have been established: discovery proteomics utilizing Hyper Reaction Monitoring for protein identification and quantification, and targeted proteomics employing Multiple and Parallel Reaction Monitoring for predefined proteins. Products offered include workflow kits, multiplexed assay panels such as Plasma dive, and software tools like Spectronaut. Services are provided based on these technologies for research applications.
Who are the top competitors of Biognosys?
Biognosys's top competitors include Somalogic, Vividion Therapeutics and Cyrus Biotechnology.
What products or services does Biognosys offer?
Biognosys offers TrueDiscovery, Spectronaut, and NULISAseq.
Who are Biognosys's investors?
Biognosys has 6 investors. Key investors include Zurcher Kantonalbank, Bruker, European Union, Redalpine, and Hellmut Kirchner.